Related Experiment Video
Updated: Jan 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sex-Specific Differences in Patients with Hypertrophic Cardiomyopathy: A Cohort Study from Vienna
Christopher Mann1, Rodi Tosun1, Shehroz Masood1
1Department of Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.
Women with hypertrophic cardiomyopathy (HCM) are diagnosed later, presenting with more severe symptoms and obstructive physiology. Recognizing these sex-specific differences in HCM is vital for improved diagnosis and tailored treatment.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is a common inherited cardiovascular disease, more prevalent in males.
- Previous research indicates women with HCM face delayed diagnosis, advanced disease stages, pronounced symptoms, and poorer outcomes.
Purpose of the Study:
- To investigate sex-specific differences in clinical, laboratory, and imaging characteristics of HCM patients.
- To analyze data from a contemporary cohort at a tertiary referral center in Austria.
Main Methods:
- Retrospective analysis of 321 HCM patients from a prospective registry (2018-2024).
- Comprehensive baseline evaluation including medical history, lab tests, echocardiography, and cardiac MRI.
Main Results:
- Women diagnosed with HCM were older (62 vs. 53 years) and presented with more advanced symptoms (NYHA ≥ II: 80% vs. 49%).
- Obstructive HCM was more prevalent in women (55% vs. 32%), with lower 6-minute walking distance (425 vs. 505 m).
- Women showed higher diastolic filling pressures (E/E' 18 vs. 10), larger indexed atrial volumes, higher LVEF (70% vs. 62%), increased septal thickness, and elevated NT-proBNP (760 vs. 338 pg/L).
Conclusions:
- Female HCM patients are diagnosed later, exhibit more advanced symptoms, and have higher rates of obstructive physiology.
- The female HCM phenotype includes diastolic dysfunction and elevated biomarkers, resembling heart failure with preserved ejection fraction.
- Addressing sex-specific disparities is essential for enhancing diagnostic awareness and personalizing therapeutic strategies in HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Sex-linked Disorders
Cardiomyopathy V: Interprofessional Care
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...

